- Nestle (OTCPK:NSRGY, OTCPK:NSRGF) discloses it invested $43M in protein developer Pronutria Biosciences.
- Pronutria aims to develop a product to help with treatment and prevention of neurological, muscle, and liver diseases.
- On a broader scale, Nestle is looking to beef up its health science unit through M&A and startup investing.
Nestle invests in protein startup
Recommended For You
More Trending News
About NSRGY Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| NSRGY | - | - |
| Nestlé S.A. | ||